AVTX
Price
$3.73
Change
-$0.06 (-1.58%)
Updated
May 23, 04:49 PM (EDT)
Capitalization
42.34M
PHGE
Price
$0.52
Change
-$0.01 (-1.89%)
Updated
May 23, 04:59 PM (EDT)
Capitalization
13.89M
Interact to see
Advertisement

AVTX vs PHGE

Header iconAVTX vs PHGE Comparison
Open Charts AVTX vs PHGEBanner chart's image
Avalo Therapeutics
Price$3.73
Change-$0.06 (-1.58%)
Volume$300
Capitalization42.34M
BiomX
Price$0.52
Change-$0.01 (-1.89%)
Volume$479
Capitalization13.89M
AVTX vs PHGE Comparison Chart
Loading...
AVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVTX vs. PHGE commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVTX is a Hold and PHGE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 23, 2025
Stock price -- (AVTX: $3.79 vs. PHGE: $0.53)
Brand notoriety: AVTX and PHGE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVTX: 0% vs. PHGE: 33%
Market capitalization -- AVTX: $42.34M vs. PHGE: $13.89M
AVTX [@Biotechnology] is valued at $42.34M. PHGE’s [@Biotechnology] market capitalization is $13.89M. The market cap for tickers in the [@Biotechnology] industry ranges from $307B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVTX’s FA Score shows that 0 FA rating(s) are green whilePHGE’s FA Score has 0 green FA rating(s).

  • AVTX’s FA Score: 0 green, 5 red.
  • PHGE’s FA Score: 0 green, 5 red.
According to our system of comparison, PHGE is a better buy in the long-term than AVTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVTX’s TA Score shows that 5 TA indicator(s) are bullish while PHGE’s TA Score has 3 bullish TA indicator(s).

  • AVTX’s TA Score: 5 bullish, 3 bearish.
  • PHGE’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, AVTX is a better buy in the short-term than PHGE.

Price Growth

AVTX (@Biotechnology) experienced а -1.81% price change this week, while PHGE (@Biotechnology) price change was -5.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.05%. For the same industry, the average monthly price growth was +3.15%, and the average quarterly price growth was -3.91%.

Reported Earning Dates

AVTX is expected to report earnings on Mar 20, 2025.

PHGE is expected to report earnings on May 15, 2025.

Industries' Descriptions

@Biotechnology (+1.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVTX($42.3M) has a higher market cap than PHGE($13.9M). AVTX has higher P/E ratio than PHGE: AVTX (0.03) vs PHGE (0.02). PHGE YTD gains are higher at: -27.298 vs. AVTX (-48.991). PHGE has higher annual earnings (EBITDA): -5.11M vs. AVTX (-35.84M). AVTX has more cash in the bank: 81.9M vs. PHGE (23.5M). AVTX has less debt than PHGE: AVTX (550K) vs PHGE (9.75M). AVTX has higher revenues than PHGE: AVTX (820K) vs PHGE (0).
AVTXPHGEAVTX / PHGE
Capitalization42.3M13.9M304%
EBITDA-35.84M-5.11M702%
Gain YTD-48.991-27.298179%
P/E Ratio0.030.02143%
Revenue820K0-
Total Cash81.9M23.5M349%
Total Debt550K9.75M6%
FUNDAMENTALS RATINGS
AVTX vs PHGE: Fundamental Ratings
AVTX
PHGE
OUTLOOK RATING
1..100
62
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
38
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9495
PRICE GROWTH RATING
1..100
9487
P/E GROWTH RATING
1..100
9955
SEASONALITY SCORE
1..100
95n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PHGE's Valuation (38) in the null industry is somewhat better than the same rating for AVTX (84) in the Pharmaceuticals Other industry. This means that PHGE’s stock grew somewhat faster than AVTX’s over the last 12 months.

PHGE's Profit vs Risk Rating (100) in the null industry is in the same range as AVTX (100) in the Pharmaceuticals Other industry. This means that PHGE’s stock grew similarly to AVTX’s over the last 12 months.

AVTX's SMR Rating (94) in the Pharmaceuticals Other industry is in the same range as PHGE (95) in the null industry. This means that AVTX’s stock grew similarly to PHGE’s over the last 12 months.

PHGE's Price Growth Rating (87) in the null industry is in the same range as AVTX (94) in the Pharmaceuticals Other industry. This means that PHGE’s stock grew similarly to AVTX’s over the last 12 months.

PHGE's P/E Growth Rating (55) in the null industry is somewhat better than the same rating for AVTX (99) in the Pharmaceuticals Other industry. This means that PHGE’s stock grew somewhat faster than AVTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVTXPHGE
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 3 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 9 days ago
78%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 3 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
AVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LNC32.670.05
+0.15%
Lincoln National Corp
KRO6.68N/A
N/A
Kronos Worldwide
AIG82.63N/A
N/A
American International Group
AKTX1.24N/A
N/A
Akari Therapeutics plc
LINC21.44N/A
N/A
Lincoln Educational Services Corp

AVTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVTX has been loosely correlated with FGEN. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if AVTX jumps, then FGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVTX
1D Price
Change %
AVTX100%
N/A
FGEN - AVTX
57%
Loosely correlated
N/A
MEOBF - AVTX
46%
Loosely correlated
N/A
MRSN - AVTX
37%
Loosely correlated
+10.39%
PGEN - AVTX
34%
Loosely correlated
N/A
BDRX - AVTX
32%
Poorly correlated
N/A
More

PHGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHGE has been loosely correlated with APM. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if PHGE jumps, then APM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHGE
1D Price
Change %
PHGE100%
N/A
APM - PHGE
60%
Loosely correlated
-4.58%
HOFBF - PHGE
35%
Loosely correlated
N/A
NRIX - PHGE
27%
Poorly correlated
+2.15%
AVTX - PHGE
26%
Poorly correlated
N/A
CABA - PHGE
24%
Poorly correlated
-0.84%
More